Role of FDG-PET in Evaluation of Myocardial Viability

Area of Science:

• Cardiology
• Nuclear Medicine
• Medical Imaging

Background:

• Chronic coronary artery disease often leads to impaired left ventricular function.
• This dysfunction can result from hibernating or ischemic myocardium, not just scar tissue.
• Identifying viable myocardium is crucial for improving heart failure prognosis.

Purpose of the Study:

• To review the role of F18-fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in assessing myocardial viability.
• To highlight the importance of viability testing in managing patients with chronic left ventricular dysfunction.
• To guide therapeutic decisions regarding coronary artery revascularization.

Main Methods:

• Review of existing literature on FDG-PET myocardial viability testing.
• Analysis of patient management strategies in chronic left ventricular dysfunction.
• Focus on the impact of viability assessment on revascularization decisions.

Main Results:

• FDG-PET can differentiate between viable and scarred myocardium.
• Identification of viable myocardium predicts improved left ventricular function post-revascularization.
• Viability testing helps select appropriate candidates for revascularization.

Conclusions:

• Myocardial viability testing, particularly FDG-PET, is essential in managing heart failure patients with chronic left ventricular dysfunction.
• It enables the identification of patients who may benefit from coronary artery revascularization.
• FDG-PET guided revascularization can favorably alter prognosis in selected patients.